Cargando…

Modeling human cancer cachexia in colon 26 tumor-bearing adult mice

BACKGROUND: Muscle wasting is a profound side effect of advanced cancer. Cancer-induced cachexia decreases patient quality of life and is associated with poor patient survival. Currently, no clinical therapies exist to treat cancer-induced muscle wasting. Although cancers commonly associated with ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Talbert, Erin E., Metzger, Gregory A., He, Wei A., Guttridge, Denis C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4248405/ https://www.ncbi.nlm.nih.gov/pubmed/24668658 http://dx.doi.org/10.1007/s13539-014-0141-2

Ejemplares similares

Oral Treatment with the Ghrelin Receptor Agonist HM01 Attenuates Cachexia in Mice Bearing Colon-26 (C26) Tumors
por: Villars, Fabienne O., et al.
Publicado: (2017)

Tumour inoculation site-dependent induction of cachexia in mice bearing colon 26 carcinoma
por: Matsumoto*, T, et al.
Publicado: (1999)

A Ketogenic Formula Prevents Tumor Progression and Cancer Cachexia by Attenuating Systemic Inflammation in Colon 26 Tumor-Bearing Mice
por: Nakamura, Kentaro, et al.
Publicado: (2018)

Trabectedin and Lurbinectedin Extend Survival of Mice Bearing C26 Colon Adenocarcinoma, without Affecting Tumor Growth or Cachexia
por: Aquila, Giorgio, et al.
Publicado: (2020)

Characterization of Mice Bearing Subclones of Colon 26 Adenocarcinoma Disqualifies Interleukin‐6 as the Sole Inducer of Cachexia
por: Soda, Kuniyasu, et al.
Publicado: (1994)

Aging Aggravates Cachexia in Tumor-Bearing Mice
por: Geppert, Julia, et al.
Publicado: (2021)

Effect of Sipjeondaebo-Tang on Cancer-Induced Anorexia and Cachexia in CT-26 Tumor-Bearing Mice
por: Choi, Youn Kyung, et al.
Publicado: (2014)

Increased Hepatic Nicotinamide N‐Methyltransferase Activity as a Marker of Cancer Cachexia in Mice Bearing Colon 26 Adenocarcinoma
por: Okamura, Atsushi, et al.
Publicado: (1998)

Inflammation Based Regulation of Cancer Cachexia
por: Onesti, Jill K., et al.
Publicado: (2014)

Modeling Human Cancer-induced Cachexia
por: Talbert, Erin E., et al.
Publicado: (2019)

Bile Acid Dysregulation Is Intrinsically Related to Cachexia in Tumor-Bearing Mice
por: Thibaut, Morgane M., et al.
Publicado: (2021)

Higher tumor mass and lower adipose mass are associated with colon-26 adenocarcinoma-induced cachexia in male, female and ovariectomized mice
por: Banh, Taylor, et al.
Publicado: (2019)

High-intensity eccentric training ameliorates muscle wasting in colon 26 tumor-bearing mice
por: Tatebayashi, Daisuke, et al.
Publicado: (2018)

Inflammation as a Therapeutic Target in Cancer Cachexia
por: Clamon, Gerald, et al.
Publicado: (2022)

IL-6 is dispensable for causing cachexia in the colon carcinoma 26 model
por: Kwon, Young-Yon, et al.
Publicado: (2023)

Hochuekkito (TJ-41), a Kampo Formula, Ameliorates Cachexia Induced by Colon 26 Adenocarcinoma in Mice
por: Yae, Suzu, et al.
Publicado: (2012)

Tumour‐derived leukaemia inhibitory factor is a major driver of cancer cachexia and morbidity in C26 tumour‐bearing mice
por: Kandarian, Susan C., et al.
Publicado: (2018)

Circulating monocyte chemoattractant protein‐1 (MCP‐1) is associated with cachexia in treatment‐naïve pancreatic cancer patients
por: Talbert, Erin E., et al.
Publicado: (2018)

The impact of inflammation and acute phase activation in cancer cachexia
por: Robinson, Tyler P., et al.
Publicado: (2023)

Serum immunoglobulin fused interferon-α inhibited tumor growth in athymic mice bearing colon 26 adenocarcinoma cells
por: Kim, Jun-Sung, et al.
Publicado: (2008)

Humoral mediation for cachexia in tumour-bearing rats.
por: Tessitore, L., et al.
Publicado: (1993)

Chemotherapy-induced muscle wasting: association with NF-κB and cancer cachexia
por: Damrauer, Jeffrey S., et al.
Publicado: (2018)

Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour‐bearing mice
por: Brown, Jacob L., et al.
Publicado: (2017)

Using transcriptomics to identify and validate novel biomarkers of human skeletal muscle cancer cachexia
por: Stephens, Nathan A, et al.
Publicado: (2010)

Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse
por: Aulino, Paola, et al.
Publicado: (2010)

An invitation to the 2nd Cancer Cachexia Conference, Montréal, Canada
por: Guttridge, Denis, et al.
Publicado: (2014)

Small-Molecule Chemical Knockdown of MuRF1 in Melanoma Bearing Mice Attenuates Tumor Cachexia Associated Myopathy
por: Adams, Volker, et al.
Publicado: (2020)

STAT3 Activation in Skeletal Muscle Links Muscle Wasting and the Acute Phase Response in Cancer Cachexia
por: Bonetto, Andrea, et al.
Publicado: (2011)

Evaluating potential biomarkers of cachexia and survival in skeletal muscle of upper gastrointestinal cancer patients
por: Stephens, Nathan A, et al.
Publicado: (2015)

Adipose atrophy in cancer cachexia: morphologic and molecular analysis of adipose tissue in tumour-bearing mice
por: Bing, C, et al.
Publicado: (2006)

Effects of photodynamic hyperthermal therapy with indocyanine green on tumor growth in a colon 26 tumor-bearing mouse model
por: ONOYAMA, MASAKI, et al.
Publicado: (2014)

Theophylline is able to partially revert cachexia in tumour-bearing rats
por: Olivan, Mireia, et al.
Publicado: (2012)

Induction of cachexia in mice
por: Tisdale, M
Publicado: (1999)

The immunomodulatory activities of licorice polysaccharides (Glycyrrhiza uralensis Fisch.) in CT 26 tumor-bearing mice
por: Ayeka, Peter Amwoga, et al.
Publicado: (2017)

GDNF family receptor alpha‐like antagonist antibody alleviates chemotherapy‐induced cachexia in melanoma‐bearing mice
por: Lee, Beom Yong, et al.
Publicado: (2023)

Fungal Dysbiosis Correlates with the Development of Tumor-Induced Cachexia in Mice
por: Jabes, Daniela L., et al.
Publicado: (2020)

Antitumor activity of melinjo (Gnetum gnemon L.) seed extract in human and murine tumor models in vitro and in a colon-26 tumor-bearing mouse model in vivo
por: Narayanan, Narayanan K, et al.
Publicado: (2015)

Synergistic Effect of Ginsenoside Rh2 Combines with Ionizing Radiation on CT26/luc Colon Carcinoma Cells and Tumor-Bearing Animal Model
por: Lee, Shan-Chih, et al.
Publicado: (2023)

Differential Bone Loss in Mouse Models of Colon Cancer Cachexia
por: Bonetto, Andrea, et al.
Publicado: (2017)

(1)H NMR-Based Metabolomics Reveals the Antitumor Mechanisms of Triptolide in BALB/c Mice Bearing CT26 Tumors
por: Li, Cheng, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_m94a50g4g3oj0aid6h8afp5f74